For citations:
Susekov A.V., Zubareva M.Yu., Tripoten’ M.I., Rozhkova T.A., Pogorelova O.A., Balakhonova T.V., Masenko V.P., Kukharchuk V.V. Randomized «FARVATER» study. Atorvastatin (10 and 20 mg/d) in treating patients with coronary heart disease and dyslipidemia: effects on lipids, C-reactive protein and fibrinogen levels. Cardiovascular Therapy and Prevention. 2006;5(6):37-45. (In Russ.)